Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML

Autoria(s): McCann, Shaun R; Gately, Kathy; Conneally, Eibhlin; Lawler, Mark; Lawler, Mark
Data(s)

01/02/2003
Identificador

http://pure.qub.ac.uk/portal/en/publications/molecular-response-to-imatinib-mesylate-following-relapse-after-allogeneic-sct-for-cml(72729b7e-edab-481d-96e2-695174ce2cd8).html

http://dx.doi.org/10.1182/blood-2002-09-2932
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

McCann , S R , Gately , K , Conneally , E , Lawler , M & Lawler , M 2003 , ' Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML ' Blood , vol 101 , no. 3 , pp. 1200-1 . DOI: 10.1182/blood-2002-09-2932
Palavras-Chave #Benzamides #Fusion Proteins, bcr-abl #Hematopoietic Stem Cell Transplantation #Humans #Leukemia, Myelogenous, Chronic, BCR-ABL Positive #Piperazines #Pyrimidines #RNA, Messenger #Recurrence #Remission Induction #Transplantation, Homologous
Tipo

article
Acesso ao item digital